These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 16996541)
1. Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions. Therrien C; Dodig D; Karpati G; Sinnreich M J Neurol Sci; 2006 Dec; 250(1-2):71-8. PubMed ID: 16996541 [TBL] [Abstract][Full Text] [Related]
2. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding. Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711 [TBL] [Abstract][Full Text] [Related]
3. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies. Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic dysferlin gene mutation carriers: characterization of two cases. Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450 [TBL] [Abstract][Full Text] [Related]
5. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. van der Kooi AJ; Frankhuizen WS; Barth PG; Howeler CJ; Padberg GW; Spaans F; Wintzen AR; Wokke JH; van Ommen GJ; de Visser M; Bakker E; Ginjaar HB Neurology; 2007 Jun; 68(24):2125-8. PubMed ID: 17562833 [TBL] [Abstract][Full Text] [Related]
6. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Piccolo F; Moore SA; Ford GC; Campbell KP Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547 [TBL] [Abstract][Full Text] [Related]
7. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828 [TBL] [Abstract][Full Text] [Related]
9. Dysferlin and muscular dystrophy. Bushby KM Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285 [TBL] [Abstract][Full Text] [Related]
10. Dysferlin and the plasma membrane repair in muscular dystrophy. Bansal D; Campbell KP Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638 [TBL] [Abstract][Full Text] [Related]
11. Proteomic investigation of the molecular pathophysiology of dysferlinopathy. De Palma S; Morandi L; Mariani E; Begum S; Cerretelli P; Wait R; Gelfi C Proteomics; 2006 Jan; 6(1):379-85. PubMed ID: 16302276 [TBL] [Abstract][Full Text] [Related]
12. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF. Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727 [TBL] [Abstract][Full Text] [Related]
13. Defective myotilin homodimerization caused by a novel mutation in MYOT exon 9 in the first Japanese limb girdle muscular dystrophy 1A patient. Shalaby S; Mitsuhashi H; Matsuda C; Minami N; Noguchi S; Nonaka I; Nishino I; Hayashi YK J Neuropathol Exp Neurol; 2009 Jun; 68(6):701-7. PubMed ID: 19458539 [TBL] [Abstract][Full Text] [Related]
14. The third human FER-1-like protein is highly similar to dysferlin. Britton S; Freeman T; Vafiadaki E; Keers S; Harrison R; Bushby K; Bashir R Genomics; 2000 Sep; 68(3):313-21. PubMed ID: 10995573 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of the dysferlin skeletal muscle promoter. Foxton RM; Laval SH; Bushby KM Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310 [TBL] [Abstract][Full Text] [Related]
16. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected]. Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732 [TBL] [Abstract][Full Text] [Related]
17. Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy. Sinnreich M; Therrien C; Karpati G Neurology; 2006 Apr; 66(7):1114-6. PubMed ID: 16606933 [TBL] [Abstract][Full Text] [Related]
18. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147 [TBL] [Abstract][Full Text] [Related]
19. In silico functional and structural characterisation of ferlin proteins by mapping disease-causing mutations and evolutionary information onto three-dimensional models of their C2 domains. Jiménez JL; Bashir R J Neurol Sci; 2007 Sep; 260(1-2):114-23. PubMed ID: 17512949 [TBL] [Abstract][Full Text] [Related]
20. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]